Improving clinical outcome measurements of fracture treatment
With the new AO Trauma Clinical Priority Program (CPP) Patient Outcome, orthopedic surgeons and scientists recognize the importance of outcome measurement in fracture treatment.
12 April 2019
Group picture of participants in the AO Trauma Clinical Priority Program (CPP) on patient outcome kick-off meeting
In order to further the goal of expanding clinical knowledge, AO Trauma has established a new Clinical Priority Program (CPP) with six projects focusing on the patient outcome.
The first investigator meeting of the AO Trauma CPP Patient Outcome took place March 3, 2019, in Boston (US). The consortium aims to produce a comprehensive body of patient outcome research involving patient-reported outcome (PRO) measurement and technology-enabled patient-derived gait measurement to advance knowledge, clinical applications, and decision-making in extremity fracture treatment, aftercare, and rehabilitation.
A total of 3,500 patients—700 for each of five fracture types: hip fractures, tibial shaft fractures, ankle/pilon fractures, proximal humerus fractures, and distal radius fractures—from 12 locations in Europe and the United States will be involved in the study.
“It is the start of an exciting five-year collaboration to improve patient treatment”
Marilyn Heng, CPP Patient Outcome core team leader
"The meeting was the occasion to have an open discussion about the projects, to define timelines and plan next steps," said CPP Patient Outcome core team leader Marilyn Heng. "It is the start of an exciting five-year collaboration to improve patient treatment."
AO Trauma CPPs were started to improve patient care worldwide by delivering competency-based, state-of-the-art learning experiences and educated faculty to health-care providers globally.
Berton Roy Moed, Chairperson AO Trauma Research Commission, introducing AO Trauma research activities 
Stephen Gwilym, University of Oxford, UK, in discussion Core team leader
Marilyn Heng
Boston, United States
Core team members
Tim Pohlemann
Homburg, Germany
Mark Vrahas
Los Angeles, United States
Benedikt Braun
Homburg, Germany
Prakash Jayakumar
Austin, United States
In collaboration with:
Barts Health, The Royal London Hospital & UCL Partners, United Kingdom
BG Trauma Center Murnau, Germany
BG Trauma Center Tübingen, Germany
Brigham and Women’s Hospital, United States
Cedars-Sinai Medical Center, United States
Charité – Universitätsmedizin Berlin, Germany
Fundación de Santa Fe, Colombia
German Research Center for Artificial Intelligence, Germany
Institute for Work and Health, Canada
Massachusetts General Hospital, United States
McMaster University, Canada
Northwestern University, United States
Saarland University Hospital, Germany
University Hospital Freiburg, Germany
University of Oxford, United Kingdom
University of Texas at Austin, United States
Wilhelminenspital, Austria
AO Clinical Investigation and Documentation (AOCID), Switzerland
AO Research Institute Davos (ARI), Switzerland